[Studying the hepatoprotector effect of bemithyl on a model of chronic toxic liver damage].
Oskovityĭ SV, Bezborodkina NN, Zarubina IV, Mironova OP, Kudrivtsev BN, Shulenin SN · 2006 · Eksperimental'naia i klinicheskaia farmakologiia; 2006 Mar-Apr
Study findings
In experimental rat cirrhosis, bemithyl improved selected liver-function, antioxidant and histological measures and reduced fibrosis severity.
- Population and setting
- Experimental animals or tissue preparations
- Evidence type
- Animal / experimental
- Preparation
- See the original report; formulation details require verification.
- Source language
- rus
- Title source
- Title as recorded in the linked source or index. A separate original-language title has not been transcribed unless shown above.
Study limitations
- Full text and detailed methods have not been independently assessed.
- Experimental or incompletely specified settings do not establish human efficacy, dosing or safety.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Source access and review scope
Indexed citation and English abstract checked.
Recorded source-check date: 2026-10-07. This date does not imply a completed systematic review.
Citation and original source
Original source: Oskovityĭ SV, Bezborodkina NN, Zarubina IV, Mironova OP, Kudrivtsev BN, Shulenin SN. [Studying the hepatoprotector effect of bemithyl on a model of chronic toxic liver damage]. Eksperimental'naia i klinicheskaia farmakologiia; 2006 Mar-Apr 2006.
Molekul research summary: https://molekul.io/research/bemitil-extra-16845942. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry